# Cascade Continuous Glucose Monitor (CGM) 15-Day US Performance Assessment

> **NCT04397965** · NA · UNKNOWN · sponsor: **WaveForm Technologies Inc.** · enrollment: 10 (estimated)

## Conditions studied

- Continuous Glucose Monitoring

## Interventions

- **DEVICE:** Cascade Continuous Glucose Monitor

## Key facts

- **NCT ID:** NCT04397965
- **Lead sponsor:** WaveForm Technologies Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-12
- **Primary completion:** 2021-04
- **Final completion:** 2021-05
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2020-10-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04397965

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04397965, "Cascade Continuous Glucose Monitor (CGM) 15-Day US Performance Assessment". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04397965. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*